-308G>A and -1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 10, 2009, Pages 1247-1251

  Ghazouani, Lakhdar ^a   Khalifa, Sonia Ben Hadj ^a   Abboud, Nesrine ^a   Addad, Faouzi ^b   Khalfallah, Ali Ben ^c   Brahim, Nsiri ^a   Mediouni, Mounira ^d   Almawi, Wassim Y ^e   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c Hopital Menzel Bourguiba   (Tunisia)

^d Hospital Center of Jendouba   (Tunisia)

^e ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Aatherosclerosis; Coronary artery disease; Polymorphisms; Tumor necrosis factor

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; THREONINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ETHNIC GROUP; EUROPE; FEMALE; FINLAND; FRANCE; GENE; GENE ASSIGNMENT; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TUNISIA;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; TUNISIA;

EID: 70349798897     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.287     Document Type: Article

References (34)

1. Mackay J, Mensah G. Atlas of heart disease and stroke. World Healh Organization (Organisation Mondiale de la Santé ), 2005.
2. American Artery Association. Artery disease and stroke statistics 2003 update. Dallas, TX: American Artery Association; 2002.
3. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation 2001;103:1718-1720
4. Beattie JH, Kwun IS. Is zinc deficiency a risk factor for atherosclerosis? Br J Nutr 2004;91:177-181
5. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695
6. Bonnet J. Atherosclerosis. EMC-Cardiologie Angé iologie 2005;2:436-458
7. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-2153
8. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, et al. Tumor necrosis factoralpha receptor 1 is a major predictor of mortality and new-onset artery failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation 2005;111:863-870
9. Seiler C, Pohl T, Billinger M, Meier B. Tumour necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function. Heart 2003;89:96-97
10. Maury CP, Teppo AM. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med 1989;225:333-336
11. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gö k H, et al. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 1993;44:332-337
12. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study. Circulation 2003;108:2317-2322 (Pubitemid 37413536)
13. Tentolouris C, Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Trikas A, et al. Endothelial function and proinflammatory cytokines in patients with ischemic artery disease and dilated cardiomyopathy. Int J Cardiol 2004;94:301-305
14. Kim F, Gallis B, Corson MA. TNF-alpha inhibits flow and insulin signalling leading to NO production in aortic endothelial cells. Am J Physiol Cell-Ph 2001;280:1057-1065
15. Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang R, et al. Plasma tumour necrosis factor-a and early carotid atherosclerosis in healthy middle-aged men. Eur Artery J 2002;23:376-383
16. Paleolog EM, Delasalle SA, Buurman WA, Feldmann M. Functional activities of receptors for tumor necrosis factor- alpha on human vascular endothelial cells. Blood 1994;84:2578-2590
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199
18. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-2610 (Pubitemid 39628581)
19. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, et al. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (y308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 2003;167:257-264
20. Lee EB, Kim JY, Lee YJ, Park MH, Song YW. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol 2003;64:614-620
21. Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, et al. The tumor necrosis factor promoter T-1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 2004;19:2509-2514
22. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic artery disease. Circulation 1979;59:607-608
23. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the stochastic-EM algorithm. Ann Hum Genet 2004; 68:165-177
24. Koch W, Kastrati A, Bö ttiger C, Mehilli J, von Beckerath N, Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001;159: 137-144
25. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, et al. Polymorphisms of the tumour necrosis factor-a gene, coronary artery disease and obesity. Eur J Clin Invest 1998;92:14-18
26. Keso T, Perola M, Laippala P, Ilvekoski E, Junnas TA, Mikkelsson J, et al. polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middleaged men. Atherosclerosis 2001;154: 691-697
27. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, et al. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (y308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 2003;167:257-264
28. Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 2001;31:843-851
29. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999;99:861-866
30. Wang XL, Oosterhof J. Tumour necrosis factor a G-308A polymorphism and risk for coronary artery disease. Clin Sci 2000;98:435-437
31. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000;100:263-269
32. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, et al. Association of TNFa serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006;187:408-414
33. Kamoun M, Chelbi H, Houman MH, Lacheb J, Hamzaoui K. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. Hum Immunol 2007;68:201-205
34. Atsuta Y, Ito LS, Oba-Shinjo SM, Uno M, Shinjo SK, Marie SK, et al. Associations of TNF-A-1031TT and -857TT genotypes with Helicobacter pylori seropositivity and gastric atrophy among Japanese Brazilians. Int J Clin Oncol 2006;11:140-145